2017 Opioid and Heroin Drug Summit
Event on 2017-07-11 07:00:00
MISSISSIPPI OPIOID + DRUG SUMMIT July 11-13, 2017 Broadmoor Baptist Church Madison, MS Contact Kim Mathis: Kmathis@MSMAonline.com or (601)853.6733 ext. 302 Education. Training. Collaboration. Saving lives. These are the goals of the 2017 Mississippi Opioid and Heroin Summit – an opportunity for all of us to face the epidemic that touches our families, friends and loved ones. The 3-day summit will bring together 3 communities – public safety, public health, and the public. Hear from Sam Quinones who documented the epidemic as a journalist and authored dreamland. Learn about threats and trends from public safety officials who are tracking the supply of opioids and heroin. Listen to public health and treatment advocates discuss the disease of addiction and the many tools available to prescribers and treatment professionals. Join with the families touched by addiction to hear stories of recovery and hope. Our goal is to give the audience the opportunity to be educated by speakers who have specific knowledge and expertise and their field with the intentions of taking that information and increasing patient awareness and patient outcomes among our state. TUESDAY, JULY 11, 2017 7:00 Registration 7:00 Exhibit hall opens (light breakfast provided) 8:00 Welcome and announcements: Rob Futral, Pastor Broadmoor Baptist Church (Director Dowdy & Colonel Maxwell) 8:15-8:45 The Crisis in MS, Attorney General Jim Hood (.50) Discuss the 2017 Legislative Session with a brief update. Where are we going with the opioid epidemic in terms of outcomes? How can we better prepare using state efforts? 8:45-10:15 Dreamland, The True Tale of America’s Opiate Epidemic Sam Quinones, Author, Dreamland (1.50) Describe the rise of the opioid epidemic in the us and the players involved. Provide potential policy solutions for states, communities and medical boards. 10:15-10:45 Break with exhibitors in foyer (30 minutes) 10:45-12:15 Responding to the Opioid Crisis: Marv Seppala, MD, Chief Medical Officer, Hazelden Betty Ford Foundation (1.5) Attendees will leave with an understanding of why and how to combine evidence based practices to treat those with opioid use disorders. Will learn from our experience with implementing medications for opioid use disorders in a 12-step abstinence based system. 12:15-1:30 Lunch (boxed) the Venue and the 1:30-2:00 Speaker remarks (TBT) 2:00-3:30 The Hazards of Drug Diversion Keith Berge, MD, Mayo Clinic (1.5) Participants will better recognize the hazards that drug diversion creates for all involved. The participants will be better able to protect their patients from harm. 3:30-4:00 Break with exhibitors (30 Minutes) 4:00-5:00 Discuss needs and policies related to Naloxone Williams T. (Billy) Robinson, PhD, LSU Biostatistician (1.0) Discuss landscape of Naloxone availability throughout the Gulf South. Discuss the need for law enforcement policies to increase Naloxone administration. 6:00-8:00 Family Forum : Judith Laundau, MD, Adrian Hickmon, PhD, Johnny Patout, LCSW (No CE credit will be given) TOTAL HOURS FOR THE DAY: 6.00 WEDNESDAY, JULY 12, 2017 7:00 Registration opens 7:00 Exhibit hall opens (Light breakfast provided) 8:00-8:30 Welcome and announcements (Director Dowdy & Colonel Maxwell) 8:30-10:00 Mobilizing Individuals, Families and Community for Early Recognition, Intervention and Engaged Treatment: Judith Landau, MD, DPM, LFMT, CAI, CIP, BRII, Child Psychiatrist, interventionist (1.5) Understand personal, family, and intergenerational trauma in the prevention, treatment and long term recovery from addition. Be able to assess the impact of current and past events as precipitants of opioid and other drug use and addiction. 10:00-10:30 Break with Exhibitors 10:30-12:00 Adolescents and Young Adults: the Most Vulnerable Hosts for Opioid / Heroin: Adrian Hickman, PhD. Capstone (1.5) Learn the differences between a fully matured adult brain vs young adult brain. Assess an individual client’s needs in 3 areas. Design a treatment plans that address strengths. 12:00-1:30 Boxed Lunch 1:30-2:30 Marijuana in MS, Hawkins, DEA (1.0) Discussions Around What Next After Marijuana and Its Effects. Should We Legalize Marijuana? 2:30-3:00 Break with Exhibitors 3:00-4:00 Can We Fix This? Where Are We? Where Are We Going? Tammy Reynolds, DEA (1.0) Discuss reasons for the current opioid epidemic in MS. Common street drugs will be discussed and the effects of patients addicted to illicit drugs 4:00-5:00 Panel Discussion Related to Regulatory Issues Mitch Owen JD, John Meynardi, JD & Patricia Burchell, JD (1.0) To provide the audience with an overview of opioid related criminal laws. To provide insight into how an opioid related OD develops into a criminal prosecution for persons providing drugs. 6:00-8:00 Family Forum: Darryl Strawberry & Ron Dock, CEO & Founder, Strawberry Ministries Ron is the former interventionist for the NY Yankees (No CE credit will be given) TOTAL HOURS FOR THE DAY: 6.00 THURSDAY, JULY 13, 2017 7:00 Registration 7:00 Exhibitor opens (Light breakfast provided) 8:00 Welcome and announcements (Director John Dowdy & Colonel Steven Maxwell) 8:15-9:15 Overdose, Doctor Shopping, Use and Misuse, Derryle Smith, DEA, Mississippi, (1.0) Why an opiate user switches to heroin will be discussed. Doctor shopping and the deadly consequences. 9:15-10:45 Prescriptions for Opioids Analgesics in MS: Numbers, Rates & Trend Analyses, and Utilizing the PMP. Meg Pearson, PharMD and Dana Crenshaw, AHFI CFS (1.5) Describe trends in prescriptions for opioid analgesics in MS. List 3 opioid analgesics with an increase in percent change or prescription between 2011-2014. The use of the PMP as a tool for judicious practice. 10:45-11:15 Break with 11:15-12:15 Panel Discussion with Dr. John Hall, MSBML, Phyllis Johnson, MS Board of Nursing, and Frank Gammil, MS Board of Pharmacy To discuss how boards regulate doctor shopping and are able to help detect illegal activity. Who is ethically bound to deal with the opioid epidemic and what do you do if you know of providers or prescribers breaking the law? 12:15-1:30 Lunch Lunch 1:30-2:30 Opioid Antagonist Therapy- Ongoing Recovery Support, Chappy Sledge (1.0) Participants will be able to discuss the basic neurobiology of opioids. participants will be able to identify appropriate candidates for ongoing opioid antagonist therapy 2:30-3:30 Treating the Chronically Relapsing Opiate Addict, Marsha Stone, JD, LCDC (1) Discuss the opiate epidemic and its impact on treatment providers. Explore treatment strategies for improving outcomes and reducing readmission rates. 3:30-4:30 Panel Discussion with Director John Dowdy and Deputy Director, MBN (1.0) Discuss the reasons for the current epidemic in the state of MS. Discuss common trends and how we can combat the epidemic as providers, prescribers and with law enforcement. TOTAL HOURS FOR THE DAY: 6.5 “This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the MS State Medical Association and the MS Bureau of Narcotics. MSMA is accredited by the ACCME to provide continuing medical education for physicians.” MSMA designates this live for a maximum of 18.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Mississippi Medical Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The University of Mississippi Medical Center maintains responsibility for this program and its content. The 2017 MS Opioid and Heroin Summit has been approved by NBCC for NBCC credit. MSMA is solely responsible for all aspects of the program. NBCC Approval No. SP-2875.
at Broadmoor Baptist Church
1531 Highland Colony Parkway
Madison, United States